Medical research suggests that a high concentration of indolepropionic acid in serum helps to protect a person against type 2 diabetes. Indolepropionic acid is produced by intestinal bacteria, and it is higher with a fiber-rich diet.
Medical researchers have discovered that a diet yielding high amounts of the short-chain fatty acids — acetate and butyrate — can impart a beneficial effect on the immune system. This protects an individual against type 1 diabetes.
Researchers have drawn a connection between the synthetic chemicals typically found in insecticides and other garden products and an affect these play on the receptors that govern our biological clocks. The disruption could lead to diabetes.
Wearable technology continues to advance at a rapid rate, especially in the health-related field. A new smart watch, equipped with a standard heart rate monitor and step counter, can also measure glucose levels.
A new hand-held breathalyzer that allows individuals to easily assess their blood glucose levels has been developed. The device informs the user bout diabetes risk and it differs from a medical device we reported on earlier this month.
Scientists have examined a cone snail venom insulin. The inquiry into these proteins suggests they operate faster than human insulin. The natural proteins have the potential to be used as a human therapeutic medicine.
Amid reports of the rising cost of EpiPens comes news of another drug that has increased in price. Insulin has gone up in price over the years and there have been diabetes patients who can't afford it.
A standard drug used to treat type-2 diabetes, called metformin, has been shown to be effective in aiding overweight children with autism spectrum disorder (ASD) to maintain or reduce their body mass index (BMI).
A Starbucks customer in Florida got a Grand White called “Diabetes Here I Come.” He has two sisters suffering from Diabetes Type 1. Starbucks has apologized, but the customer just wants to make sure it doesn’t happen again.
The number of adults estimated to be living with diabetes has nearly quadrupled over 35 years, the World Health Organization (WHO) said Wednesday, urging huge efforts to change eating habits and exercise more.
Janssen Pharmaceuticals and Bayer AG announced 13 data presentations at the American College of Cardiology (ACC). The studies will include real-world data about Xarelto safety in patients with diabetes and atrial fibrillation.
The growing problem of childhood obesity has been well documented and several health initiatives are in place. These may need to be advanced following a review of symptoms of heart disease in children.
It has been a busy week for announcements about new medications to address serious medical conditions. Drugs are in the development pipeline for eye care and to help people manage complications associated with diabetes.
University of Alberta researchers say they have made a discovery which could be a "game changer" in the fight against Type 2 diabetes. Their research was published this week and is getting plenty of press.
A health body has called for tighter blood sugar guidelines in order to help those with diabetes manage the condition better as well as to improve the chances of detecting diabetes earlier. This applies to children and adults.